TenSixteen Bio
San Francisco
About TenSixteen Bio
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: tensixteen.bio
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tensixteen-bio-129300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.